These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1736276)

  • 1. Evidence for a non-estrogenic cytostatic effect of estramustine on human prostatic carcinoma cells in vivo.
    Eklöv S; Nilsson S; Larson A; Björk P; Hartley-Asp B
    Prostate; 1992; 20(1):43-50. PubMed ID: 1736276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estramustine-induced mitotic arrest in two human prostatic carcinoma cell lines DU 145 and PC-3.
    Hartley-Asp B
    Prostate; 1984; 5(1):93-100. PubMed ID: 6694918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of estramustine on metaphase and anaphase in DU 145 prostatic carcinoma cells.
    Sheridan VR; Speicher LA; Tew KD
    Eur J Cell Biol; 1991 Apr; 54(2):268-76. PubMed ID: 1879438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake of estramustine phosphate (estracyt) metabolites in prostatic cancer.
    Norlén BJ; Andersson SB; Björk P; Gunnarsson PO; Fritjofsson A
    J Urol; 1988 Nov; 140(5):1058-62. PubMed ID: 3172360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estramustine potentiates the radiation effect in human prostate tumor transplant in nude mice.
    Eklöv S; Westlin JE; Rikner G; Nilsson S
    Prostate; 1994; 24(1):39-45. PubMed ID: 8290388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation sensitization by estramustine studies on cultured human prostatic cancer cells.
    Eklöv S; Essand M; Carlsson J; Nilsson S
    Prostate; 1992; 21(4):287-95. PubMed ID: 1461806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of docetaxel with or without estramustine phosphate versus mitoxantrone in androgen dependent and independent human prostate cancer xenografts.
    Oudard S; Legrier ME; Boyé K; Bras-Gonçalves R; De Pinieux G; De Cremoux P; Poupon MF
    J Urol; 2003 May; 169(5):1729-34. PubMed ID: 12686819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation sensitizing effect of estramustine is not dependent on apoptosis.
    Ståhlberg K; Kairemo K; Erkkilä K; Pentikäinen V; Sorvari P; Taari K; Dunkel L; Rannikko S
    Anticancer Res; 2005; 25(4):2873-8. PubMed ID: 16080540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma concentrations of estramustine phosphate and its major metabolites in patients with prostatic carcinoma treated with different doses of estramustine phosphate (Estracyt).
    Gunnarsson PO; Forshell GP; Fritjofsson A; Norlén BJ
    Scand J Urol Nephrol; 1981; 15(3):201-5. PubMed ID: 7323739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estramustine-binding protein (EMBP) content in four different cell lines and its correlation to estramustine induced metaphase arrest.
    Eklöv S; Mahdy E; Wester K; Björk P; Malmström PU; Busch C; Nilsson S
    Anticancer Res; 1996; 16(4A):1819-22. PubMed ID: 8712706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of glutathione depletion and inhibition of glutathione-S-transferase activity to the antimitotic properties of estramustine.
    Tew KD; Woodworth A; Stearns ME
    Cancer Treat Rep; 1986 Jun; 70(6):715-20. PubMed ID: 3731136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined antimicrotubule activity of estramustine and taxol in human prostatic carcinoma cell lines.
    Speicher LA; Barone L; Tew KD
    Cancer Res; 1992 Aug; 52(16):4433-40. PubMed ID: 1353706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estramustine-binding protein (EMBP) in renal cell carcinoma immunohistochemistry, immunoscintigraphy and in vitro estramustine effects.
    Edgren M; Westlin JE; Letocha H; Nordgren H; Kälkner KM; Nilsson S
    Acta Oncol; 1996; 35(4):483-8. PubMed ID: 8695166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estramustine phosphate: metabolic aspects related to its action in prostatic cancer.
    Kadohama N; Kirdani RY; Murphy GP; Sandberg AA
    J Urol; 1978 Feb; 119(2):234-9. PubMed ID: 633484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth of prostatic cancer cells, DU 145, as multicellular spheroids and effects of estramustine.
    Essand M; Nilsson S; Carlsson J
    Anticancer Res; 1993; 13(5A):1261-8. PubMed ID: 8239495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estramustine phosphate-reduced proliferation of murine and human cell lines and murine transplantable tumors.
    Pavelić K; Zgradić I; Osmak M; Popović M
    Res Exp Med (Berl); 1985; 185(3):233-43. PubMed ID: 3860896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difference in uptake of 3H-estramustine in two human prostatic carcinoma cell lines, LNCaP and LNCaP-r.
    Hasenson M
    Urol Res; 1989; 17(2):103-6. PubMed ID: 2734976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen antagonistic effect of estramustine phosphate (EMP) metabolites on wild-type and mutated androgen receptor.
    Wang LG; Liu XM; Kreis W; Budman DR
    Biochem Pharmacol; 1998 May; 55(9):1427-33. PubMed ID: 10076535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of estramustine phosphate.
    Bergenheim AT; Henriksson R
    Clin Pharmacokinet; 1998 Feb; 34(2):163-72. PubMed ID: 9515186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the effect of diethylstilbestrol with low dose estramustine phosphate in the treatment of advanced prostatic cancer: final analysis of a phase III trial of the European Organization for Research on Treatment of Cancer.
    Smith PH; Suciu S; Robinson MR; Richards B; Bastable JR; Glashan RW; Bouffioux C; Lardennois B; Williams RE; de Pauw M
    J Urol; 1986 Sep; 136(3):619-23. PubMed ID: 3525866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.